Viewing Study NCT00622700


Ignite Creation Date: 2025-12-26 @ 12:15 PM
Ignite Modification Date: 2026-01-13 @ 10:45 AM
Study NCT ID: NCT00622700
Status: COMPLETED
Last Update Posted: 2017-03-13
First Post: 2008-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Sponsor:
Organization: